UBS Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Sell |
630,359
-586,015
| -48% | -$1.29M | ﹤0.01% | 4103 |
|
|
2025
Q1 | $1.41M | Buy |
1,216,374
+101,294
| +9% | +$118K | ﹤0.01% | 3947 |
|
|
2024
Q4 | $1.42M | Buy |
1,115,080
+704,471
| +172% | +$895K | ﹤0.01% | 3972 |
|
|
2024
Q3 | $1.4M | Buy |
410,609
+68,488
| +20% | +$234K | ﹤0.01% | 3306 |
|
|
2024
Q2 | $1.6M | Sell |
342,121
-253,844
| -43% | -$1.19M | ﹤0.01% | 3034 |
|
|
2024
Q1 | $4.42M | Buy |
595,965
+451,956
| +314% | +$3.35M | ﹤0.01% | 2300 |
|
|
2023
Q4 | $1.46M | Buy |
144,009
+35,167
| +32% | +$356K | ﹤0.01% | 3133 |
|
|
2023
Q3 | $849K | Sell |
108,842
-76,799
| -41% | -$599K | ﹤0.01% | 3218 |
|
|
2023
Q2 | $1.53M | Sell |
185,641
-312,223
| -63% | -$2.57M | ﹤0.01% | 2922 |
|
|
2023
Q1 | $3.61M | Buy |
497,864
+90,850
| +22% | +$659K | ﹤0.01% | 2098 |
|
|
2022
Q4 | $3.61M | Buy |
407,014
+318,113
| +358% | +$2.82M | ﹤0.01% | 2093 |
|
|
2022
Q3 | $1.09M | Sell |
88,901
-191,963
| -68% | -$2.35M | ﹤0.01% | 2790 |
|
|
2022
Q2 | $3.32M | Buy |
280,864
+39,281
| +16% | +$465K | ﹤0.01% | 2049 |
|
|
2022
Q1 | $4.6M | Buy |
241,583
+100,148
| +71% | +$1.9M | ﹤0.01% | 1991 |
|
|
2021
Q4 | $3.76M | Buy |
141,435
+45,839
| +48% | +$1.22M | ﹤0.01% | 2368 |
|
|
2021
Q3 | $3.93M | Sell |
95,596
-4,845
| -5% | -$199K | ﹤0.01% | 2221 |
|
|
2021
Q2 | $5.69M | Buy |
100,441
+43,110
| +75% | +$2.44M | ﹤0.01% | 1906 |
|
|
2021
Q1 | $2.41M | Sell |
57,331
-30,804
| -35% | -$1.29M | ﹤0.01% | 2601 |
|
|
2020
Q4 | $6.18M | Buy |
88,135
+25,822
| +41% | +$1.81M | ﹤0.01% | 1687 |
|
|
2020
Q3 | $1.75M | Sell |
62,313
-6,905
| -10% | -$194K | ﹤0.01% | 2507 |
|
|
2020
Q2 | $2.05M | Buy |
69,218
+12,602
| +22% | +$373K | ﹤0.01% | 2263 |
|
|
2020
Q1 | $1.12M | Sell |
56,616
-40,819
| -42% | -$810K | ﹤0.01% | 2574 |
|
|
2019
Q4 | $2.89M | Sell |
97,435
-140,570
| -59% | -$4.16M | ﹤0.01% | 2465 |
|
|
2019
Q3 | $5.41M | Buy |
238,005
+120,159
| +102% | +$2.73M | ﹤0.01% | 1794 |
|
|
2019
Q2 | $2.92M | Sell |
117,846
-10,434
| -8% | -$258K | ﹤0.01% | 2228 |
|
|
2019
Q1 | $3.14M | Buy |
128,280
+28,664
| +29% | +$701K | ﹤0.01% | 2097 |
|
|
2018
Q4 | $2.27M | Sell |
99,616
-30,571
| -23% | -$695K | ﹤0.01% | 2340 |
|
|
2018
Q3 | $4.14M | Buy |
130,187
+36,103
| +38% | +$1.15M | ﹤0.01% | 2027 |
|
|
2018
Q2 | $3.37M | Sell |
94,084
-119,954
| -56% | -$4.3M | ﹤0.01% | 2157 |
|
|
2018
Q1 | $7.1M | Buy |
214,038
+102,947
| +93% | +$3.41M | ﹤0.01% | 1597 |
|
|
2017
Q4 | $3.41M | Sell |
111,091
-43,212
| -28% | -$1.33M | ﹤0.01% | 2137 |
|
|
2017
Q3 | $3.71M | Buy |
154,303
+62,697
| +68% | +$1.51M | ﹤0.01% | 1990 |
|
|
2017
Q2 | $1.54M | Buy |
91,606
+13,389
| +17% | +$225K | ﹤0.01% | 2602 |
|
|
2017
Q1 | $1.75M | Buy |
78,217
+68,990
| +748% | +$1.54M | ﹤0.01% | 2439 |
|
|
2016
Q4 | $150K | Sell |
9,227
-21,241
| -70% | -$345K | ﹤0.01% | 4118 |
|
|
2016
Q3 | $411K | Buy |
30,468
+13,177
| +76% | +$178K | ﹤0.01% | 3268 |
|
|
2016
Q2 | $422K | Buy |
17,291
+4,191
| +32% | +$102K | ﹤0.01% | 3263 |
|
|
2016
Q1 | $452K | Buy |
+13,100
| New | +$452K | ﹤0.01% | 3185 |
|